The US Food and Drug Administration (FDA) last month warned Indian drugmaker Centurion Laboratories over good manufacturing practice (GMP) violations observed at the company’s Gujarat facility last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results